2:53 PM
 | 
Feb 13, 2018
 |  BC Extra  |  Company News

Cytobank, FDA using machine learning to classify MSCs

Cytobank Inc. (Santa Clara, Calif.) partnered with FDA to develop machine learning-based methods for characterization of mesenchymal stromal cell morphology that could be used to improve cellular manufacturing.

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >